🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will analyze and evaluate the following items: 1. The safety of...
Status
Unknown
Location
Xuanwu Hospital
Start Date
2018-10-26
Trial ID
NCT03634501
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as busulfan and fludarabi...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2011-01-07
Trial ID
NCT00448201
This study is being done to determine the highest tolerated dose of an inve...
Status
Completed
Location
Fred Hutch/University of Washington Medical Center
Start Date
2021-08-01
Trial ID
NCT04900454
Treatments Being Tested
To determine safety profile of immunotherapy with natural killer cells and ...
Status
Completed
Location
Hospital 12 de Octubre
Start Date
2014-04
Trial ID
NCT02074657
Treatments Being Tested
Combinations Natural Killer Cell (NK) With chemotherapy treatment may enhan...
Status
Unknown
Location
Yantai Yuhuangding Hospital
Start Date
2019-12-31
Trial ID
NCT04214730
Treatments Being Tested
This phase I trial studies the side effects of donor natural killer (NK) ce...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2020-06-11
Trial ID
NCT04220684
This is a single-arm, open-label, multi-center, Phase 1 study to determine ...
Status
Active Not Recruiting
Location
Colorado Blood Cancer Institute
Start Date
2020-09-21
Trial ID
NCT04623944
Treatments Being Tested
This is a phase I study. The purpose of this study is to see if it is safe ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2016-01-05
Trial ID
NCT02650648
Treatments Being Tested
This study is a single-arm, open-label, dose-escalating + dose-expansion cl...
Status
Completed
Location
Shanxi Bethune Hospital
Start Date
2024-03-28
Trial ID
NCT06006403
Treatments Being Tested
Primary objective: * To determine the safety of adback T- or Natural Kille...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2007-09
Trial ID
NCT00536978